Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Clinical Neuropharmacology
|
February 17, 2016
The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
Peter A LeWitt, Werner Poewe, Lawrence W Elmer, et al.
Expert Opinion on Pharmacotherapy
|
December 22, 2012
Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years
Elisabeth Dohin, Birgit Högl, Luigi Ferini-Strambi, et al.
Clinical Therapeutics
|
August 13, 2018
Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects
Yun Liu, Brian Tomlinson, Jiyuan Guo, et al.
Journal of Clinical Pharmacology
|
December 3, 2015
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
Olivier Rascol, Theresa Zesiewicz, K Ray Chaudhuri, et al.
RMD Open
|
September 4, 2024
Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis
Xenofon Baraliakos, Pedro M Machado, Lars Bauer, et al.
Expert Review of Neurotherapeutics
|
May 27, 2017
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2005
Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization
Bernard M J Uitdehaag, Ludwig Kappos, Lars Bauer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 28, 2018
An observational study of rotigotine transdermal patch and other currently prescribed therapies in patients with Parkinson's disease
Thomas Müller, Eduardo Tolosa, Letitia Badea, et al.
Postgraduate Medicine
|
November 25, 2016
Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study
Lars Timmermann, Christian Oehlwein, Gerhard Ransmayr, et al.
Journal of Parkinson'S Disease
|
March 20, 2014
A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease
Anthony P Nicholas, Rupam Borgohain, Pedro Chaná, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Clinical Neuropharmacology
|
February 17, 2016
The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
Peter A LeWitt, Werner Poewe, Lawrence W Elmer, et al.
Expert Opinion on Pharmacotherapy
|
December 22, 2012
Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years
Elisabeth Dohin, Birgit Högl, Luigi Ferini-Strambi, et al.
Clinical Therapeutics
|
August 13, 2018
Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects
Yun Liu, Brian Tomlinson, Jiyuan Guo, et al.
Journal of Clinical Pharmacology
|
December 3, 2015
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
Olivier Rascol, Theresa Zesiewicz, K Ray Chaudhuri, et al.
RMD Open
|
September 4, 2024
Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis
Xenofon Baraliakos, Pedro M Machado, Lars Bauer, et al.
Expert Review of Neurotherapeutics
|
May 27, 2017
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2005
Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization
Bernard M J Uitdehaag, Ludwig Kappos, Lars Bauer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 28, 2018
An observational study of rotigotine transdermal patch and other currently prescribed therapies in patients with Parkinson's disease
Thomas Müller, Eduardo Tolosa, Letitia Badea, et al.
Postgraduate Medicine
|
November 25, 2016
Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study
Lars Timmermann, Christian Oehlwein, Gerhard Ransmayr, et al.
Journal of Parkinson'S Disease
|
March 20, 2014
A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease
Anthony P Nicholas, Rupam Borgohain, Pedro Chaná, et al.
Page
of 5